APP dyshomeostasis in the pathogenesis of Alzheimer's disease: implications for current drug targets von Sirisi, Sònia, Sánchez-Aced, Érika, Belbin, Olivia, Lleó, Alberto

Volltext

Current drug targets for helminthic diseases von Rana, Ajay Kumar, Misra-Bhattacharya, Shailja

Volltext

Implication of colloidal therapeutics in the treatment of vitiligo: Portray of signaling cascade, current drug-targets and preclinical and clinical evidences von Paul, Priti, Veerabomma, Harithasree, Gupta, Ujala, Atram, Divya, Singh, Pankaj Kumar, Mehra, Neelesh Kumar, Godugu, Chandraiah, Baldi, Ashish, Madan, Jitender

Volltext

Current drug targets for Alzheimer's disease treatment von Lahiri, Debomoy K., Farlow, Martin R., Greig, Nigel H., Sambamurti, Kumar

Volltext

Current drug targets for Alzheimer's disease treatment: New drug development for Alzheimer's disease - Part 2 von LAHIRI, Debomoy K, FARLOW, Martin R, GREIG, Nigel H, SAMBAMURTI, Kumar

Volltext

Current Drug Targets and the Druggable Genome von Johns, Margaret A., Russ, Andreas, Fu, Haian

Volltext

Genetic architecture of host proteins involved in SARS-CoV-2 infection von Pietzner, Maik, Wheeler, Eleanor, Carrasco-Zanini, Julia, Raffler, Johannes, Kerrison, Nicola D., Oerton, Erin, Auyeung, Victoria P. W., Luan, Jian’an, Finan, Chris, Casas, Juan P., Ostroff, Rachel, Williams, Steve A., Kastenmüller, Gabi, Ralser, Markus, Gamazon, Eric R., Wareham, Nicholas J., Hingorani, Aroon D., Langenberg, Claudia

Volltext

Current drugs, targets, and drug delivery systems for the treatment of dyslipidemia von Yang, Sugeun, Moon, Young-Ah

Volltext

Assessing the local structural quality of transmembrane protein models using statistical potentials (QMEANBrane) von Studer, Gabriel, Biasini, Marco, Schwede, Torsten

Volltext

Preparation of Selenoinsulin as a Long‐Lasting Insulin Analogue von Arai, Kenta, Takei, Toshiki, Okumura, Masaki, Watanabe, Satoshi, Amagai, Yuta, Asahina, Yuya, Moroder, Luis, Hojo, Hironobu, Inaba, Kenji, Iwaoka, Michio

Volltext

P3‐261: Current drug target sites in clinical practice or clinical trial, extent of disease modification for Alzheimer's disease von Ul Haq Subhani, Farhan

Volltext

P4-348: Current drug target sites in clinical practice or clinical trail: Extent of disease modification for Alzheimer's disease von Subhani, Farhan Ul Haq

Volltext

Current drug target sites in clinical practice or clinical trial, extent of disease modification for Alzheimer's disease von Ul Haq Subhani, Farhan

Volltext

Sequence-Derived Markers of Drug Targets and Potentially Druggable Human Proteins von Ghadermarzi, Sina, Li, Xingyi, Li, Min, Kurgan, Lukasz

Volltext

Network-wide risk convergence in gene co-expression identifies reproducible genetic hubs of schizophrenia risk von Borcuk, Christopher, Parihar, Madhur, Sportelli, Leonardo, Kleinman, Joel E., Shin, Joo Heon, Hyde, Thomas M., Bertolino, Alessandro, Weinberger, Daniel R., Pergola, Giulio

Volltext

Current drug target sites in clinical practice or clinical trail, extent of disease modification for alzheimer's disease von Subhani, F U Haq

Volltext

How many drug targets are there? von Overington, John P, Al-Lazikani, Bissan, Hopkins, Andrew L

Volltext

In‐Cell Arrestin‐Receptor Interaction Assays von Zheng, Chen, Javitch, Jonathan A., Lambert, Nevin A., Donthamsetti, Prashant, Gurevich, Vsevolod V.

Volltext

Drugs, their targets and the nature and number of drug targets von Imming, Peter, Sinning, Christian, Meyer, Achim

Volltext

Production of membrane proteins in industry: The example of GPCRs von Errey, James C., Fiez-Vandal, Cédric

Volltext